Genes and Gene Therapy Clinical Trials

• Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00006480 - Active, not recruiting
  disseminated neuroblastoma; Drug Toxicity; recurrent neuroblastoma
  
• Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002748 - Active, not recruiting
  recurrent neuroblastoma
  
• Gene Therapy and Surgery Followed by Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Cancer of the Mouth or Throat
  ClinicalTrials.gov Identifier: NCT00017173 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer
  ClinicalTrials.gov Identifier: NCT00004471 - Active, not recruiting
  Cystic Fibrosis
  
• Chemotherapy With or Without Gene Therapy in Treating Patients With Unresectable Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00040716 - Recruiting
  Head and Neck Cancer
  
• Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-up
  ClinicalTrials.gov Identifier: NCT00001476 - Active, not recruiting
  Chronic Granulomatous Disease; Communicable Disease
  
• Biological Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00002786 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Comparison of Gene Therapy With Chemotherapy in Treating Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00040703 - Recruiting
  Head and Neck Cancer
  
• Vaccine Therapy and Interleukin-2 in Treating Patients With Stage IV Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00031564 - Active, not recruiting
  Stage IV Renal Cell Cancer
  
• Study of TNFerade™ gene therapy, Radiation, 5-FU and Cisplatin in Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00051480 - Active, not recruiting
  Esophageal Cancer
  
• Gene Therapy for Prostate Cancer that Returns after Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00110526 - Recruiting
  Prostatic Neoplasms; Neoplasm Recurrence, Local
  
• Gene Therapy in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00036725 - Active, not recruiting
  recurrent adult brain tumor; adult glioblastoma multiforme
  
• Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus
  ClinicalTrials.gov Identifier: NCT00064025 - Recruiting
  Endometrial Cancer
  
• Vaccine Therapy With Immune Adjuvant in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00085137 - Active, not recruiting
  Recurrent Melanoma; stage II melanoma; stage III melanoma; Stage IV Melanoma
  
• Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00072098 - Recruiting
  stage IV colon cancer; Stage IV rectal cancer; liver metastases; recurrent rectal cancer; recurrent colon cancer
  
• Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00039325 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00003450 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage IV ovarian epithelial cancer
  
• Gene Therapy in Patients With Colon Cancer That Has Spread to the Liver
  ClinicalTrials.gov Identifier: NCT00012155 - Active, not recruiting
  recurrent colon cancer; liver metastases; stage IV colon cancer; adenocarcinoma of the colon
  
• Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00085462 - Active, not recruiting
  Melanoma (Skin)
  
• Gene Expression Profiling and Bioinformatic Analysis Identifying Genes and Biochemical Pathways in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00143013 - Recruiting
  Type 2 Diabetes
  
• Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00091104 - Active, not recruiting
  Melanoma (Skin)
  
• Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00004070 - Active, not recruiting
  lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) with Advate (FLrFVIII) in Hemophilia A
  ClinicalTrials.gov Identifier: NCT00141843 - Active, not recruiting
  Hemophilia A
  
• Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00055640 - Active, not recruiting
  adult diffuse large cell lymphoma; childhood diffuse large cell lymphoma; childhood large cell lymphoma
  
• Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors
  ClinicalTrials.gov Identifier: NCT00005796 - Active, not recruiting
  Brain Tumor
  
• Safety and Efficacy Study of INGN 241 Gene Therapy in Patients with In Transit Melanoma
  ClinicalTrials.gov Identifier: NCT00116363 - Recruiting
  Malignant Melanoma; Neoplasm Metastasis
  
• Trial of an Anti-HIV-1 Gene Transfer Product
  ClinicalTrials.gov Identifier: NCT00074997 - Active, not recruiting
  HIV Infections
  
• Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003942 - Active, not recruiting
  AIDS-related diffuse small cleaved cell lymphoma; AIDS-related small noncleaved cell lymphoma; AIDS-related lymphoblastic lymphoma; ...
  
• Phase I - Pre-Radical Prostatectomy RTVP-1 Gene Therapy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00403221 - Recruiting
  Prostatic Neoplasms
  
• Hormone Therapy in Treating Patients With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003026 - Active, not recruiting
  adenocarcinoma of the prostate
  
• Vaccine Therapy in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00005629 - Active, not recruiting
  recurrent adult primary liver cancer; advanced adult primary liver cancer; localized resectable adult primary liver cancer; ...
  
• Gene Therapy in Treating Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00004178 - Active, not recruiting
  Lung Cancer; Pancreatic Cancer; Gastric Cancer; Salivary Gland Cancer; Renal Cell Cancer; Endometrial Cancer; Esophageal Cancer; Head and Neck Cancer; ...
  
• Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00049374 - Active, not recruiting
  refractory plasma cell neoplasm
  
• Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
  ClinicalTrials.gov Identifier: NCT00004024 - Active, not recruiting
  adult brain tumor
  
• Gene Therapy Combined With Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer That Cannot Be Surgically Removed
  ClinicalTrials.gov Identifier: NCT00049647 - No longer recruiting
  adenocarcinoma of the pancreas; stage III pancreatic cancer
  
• Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003257 - Active, not recruiting
  recurrent squamous cell carcinoma of the hypopharynx; recurrent squamous cell carcinoma of the larynx; ...
  
• Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00023959 - Active, not recruiting
  Head and Neck Cancer
  
• SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00026377 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
  
• Follow-Up of Patients With Breast Cancer or Multiple Myeloma Previously Treated on a Gene Therapy Clinical Trial
  ClinicalTrials.gov Identifier: NCT00427726 - Active, not recruiting
  Breast Cancer; Multiple Myeloma and Plasma Cell Neoplasm
  
• Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases
  ClinicalTrials.gov Identifier: NCT00033254 - Active, not recruiting
  brain metastases
  
• Gene-Polymorphies in the P2X7 Gene in Patients With Osteoporotic Fractures
  ClinicalTrials.gov Identifier: NCT00293189 - Recruiting
  Hip Fracture
  
• Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00055913 - Active, not recruiting
  Head and Neck Cancer
  
• Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
  ClinicalTrials.gov Identifier: NCT00066404 - Active, not recruiting
  Cancer
  
• Vaccine Therapy and/or Sargramostim in Treating Patients With Locally Advanced or Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00005034 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00014560 - Active, not recruiting
  Lymphocytic Lymphoma; Non-Hodgkin's Lymphoma
  
• Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00082823 - Active, not recruiting
  Cancer
  
• Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00083213 - Active, not recruiting
  Cancer
  
• Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00006385 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Gene Therapy for the Treatment of Brain Tumors
  ClinicalTrials.gov Identifier: NCT00001328 - Active, not recruiting
  Brain Neoplasm; Neoplasm Metastasis
  
• Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients
  ClinicalTrials.gov Identifier: NCT00517569 - Recruiting
  HIV Infections
  
• Combination Chemotherapy and Filgrastim Followed by Radiation Therapy in Treating Patients With Stage II or Stage IIIA Breast Cancer
  ClinicalTrials.gov Identifier: NCT00007904 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; Male Breast Cancer
  
• Gene Therapy for the Treatment of Fanconi's Anemia Type C
  ClinicalTrials.gov Identifier: NCT00001399 - Active, not recruiting
  Fanconi's Anemia; Pancytopenia
  
• Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002560 - Active, not recruiting
  recurrent neuroblastoma
  
• Enzastaurin in Treating Patients With Recurrent Gliomas
  ClinicalTrials.gov Identifier: NCT00112788 - Active, not recruiting
  adult brain tumor
  
• Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00128700 - Active, not recruiting
  adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
  
• Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00182689 - Active, not recruiting
  Lung Cancer
  
• Phase I Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00415454 - Recruiting
  Pancreatic Cancer
  
• Biological Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00045149 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00067015 - Active, not recruiting
  adenocarcinoma of the prostate; stage III prostate cancer; Quality of Life
  
• Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00096512 - Active, not recruiting
  Head and Neck Cancer
  
• Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/neu-Expressing Cancer
  ClinicalTrials.gov Identifier: NCT00084513 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Vaccine Therapy in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00022334 - Active, not recruiting
  localized resectable adult primary liver cancer; localized unresectable adult primary liver cancer; advanced adult primary liver cancer; ...
  
• Gene Transfer Therapy for Treating Children and Adults With Limb Girdle Muscular Dystrophy Type 2D (LGMD2D)
  ClinicalTrials.gov Identifier: NCT00494195 - Recruiting
  Muscular Dystrophies
  
• Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00091299 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00108732 - Active, not recruiting
  recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• The Gene Expression Patterns in the Peripheral White Blood Cells of Type 2 Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00155922 - Recruiting
  1. Diabetes mellitus; 2. Monocyte gene expression
  
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00089206 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00028678 - Active, not recruiting
  adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
  
• Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients with Locally Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00016913 - Active, not recruiting
  adenocarcinoma of the prostate; stage III prostate cancer
  
• Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
  ClinicalTrials.gov Identifier: NCT00006734 - Active, not recruiting
  localized tumors of the Ewing's family
  
• Cetuximab, Combination Chemotherapy, and Radiation therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00109850 - Active, not recruiting
  Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage III esophageal cancer
  
• Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00003456 - Active, not recruiting
  adult glioblastoma
  
• Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00006113 - Active, not recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003653 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00084708 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00104884 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00040950 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00054522 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00015977 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00006359 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00007826 - Active, not recruiting
  Colon Cancer; Rectal Cancer
  
• Gene Therapy for Patients with Leukocyte Adherence Deficiency (Follow-Up of Phase 1 Trial)
  ClinicalTrials.gov Identifier: NCT00023010 - Active, not recruiting
  Leukocyte Adhesion Deficiency Syndrome
  
• Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00003414 - Active, not recruiting
  Lymphoma
  
• Sorafenib in Treating Patients with Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00119249 - Active, not recruiting
  Stage IV Melanoma
  
• Doxorubicin and Paclitaxel in Treating Women Who are Undergoing Surgery For Breast Cancer
  ClinicalTrials.gov Identifier: NCT00096291 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Gene Therapy for Chronic Granulomatous Disease
  ClinicalTrials.gov Identifier: NCT00564759 - Active, not recruiting
  Granulomatous Disease, Chronic
  
• GW786034 in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00060151 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005959 - Active, not recruiting
  Lymphoma
  
• Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00089219 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00089115 - Active, not recruiting
  grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma
  
• Combination Chemotherapy in Treating Women With Stage I Breast Cancer
  ClinicalTrials.gov Identifier: NCT00055679 - Active, not recruiting
  stage I breast cancer
  
• Brief Strategic Family Therapy for Adolescent Drug Abusers - 1
  ClinicalTrials.gov Identifier: NCT00095303 - Active, not recruiting
  Behavior Therapy
  
• Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004227 - Active, not recruiting
  Oral Cancer; Throat Cancer
  
• Gene Therapy for Pleural Malignancies
  ClinicalTrials.gov Identifier: NCT00299962 - Recruiting
  Pleural Mesothelioma; Metastatic Pleural Effusions
  
• Epoetin alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00060398 - Active, not recruiting
  recurrent prostate cancer; Anemia; Fatigue
  
• Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00058006 - Active, not recruiting
  Head and Neck Cancer; thorax and respiratory cancer
  
• Genes Mutation Pentalogy of Cantrell
  ClinicalTrials.gov Identifier: NCT00477932 - Recruiting
  Pentalogy of Cantrell; Mutations in Non-Muscle Genes
  
• Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00005044 - Active, not recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
  
• Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
  ClinicalTrials.gov Identifier: NCT00217620 - Active, not recruiting
  adult soft tissue sarcoma
  
• Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas
  ClinicalTrials.gov Identifier: NCT00003113 - Active, not recruiting
  Lymphoma